RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
This Quarter Return
-2.4%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.42B
AUM Growth
+$1.42B
Cap. Flow
+$25.4M
Cap. Flow %
1.79%
Top 10 Hldgs %
29.29%
Holding
97
New
3
Increased
35
Reduced
20
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EPIX icon
76
ESSA Pharma
EPIX
$11.2M
$4.8M 0.34%
600,000
+340,000
+131% +$2.72M
ANNX icon
77
Annexon
ANNX
$225M
$4.65M 0.33%
250,000
PGNY icon
78
Progyny
PGNY
$2.02B
$4.48M 0.31%
80,000
OSH
79
DELISTED
Oak Street Health, Inc.
OSH
$4.47M 0.31%
105,000
+10,000
+11% +$425K
GTHX
80
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$4.36M 0.31%
325,000
STXS icon
81
Stereotaxis
STXS
$246M
$4.3M 0.3%
800,000
+115,598
+17% +$622K
ARNA
82
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.57M 0.25%
60,000
OLK
83
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$3.4M 0.24%
+140,000
New +$3.4M
IMCR icon
84
Immunocore
IMCR
$1.78B
$3.34M 0.23%
90,000
IONS icon
85
Ionis Pharmaceuticals
IONS
$9.64B
$2.52M 0.18%
75,000
FGEN icon
86
FibroGen
FGEN
$48.4M
$2.04M 0.14%
200,000
DCPH
87
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.04M 0.14%
60,000
PVLA
88
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$1.55M 0.11%
300,000
SPRY icon
89
ARS Pharmaceuticals
SPRY
$1.08B
$1.5M 0.11%
150,000
+50,000
+50% +$499K
EPZM
90
DELISTED
Epizyme, Inc
EPZM
$1.36M 0.1%
265,000
INNV icon
91
InnovAge Holding
INNV
$509M
$992K 0.07%
150,000
XLRN
92
DELISTED
Acceleron Pharma Inc.
XLRN
$756K 0.05%
4,392
-195,608
-98% -$33.7M
REGN icon
93
Regeneron Pharmaceuticals
REGN
$59.8B
-25,000
Closed -$14M
LIVN icon
94
LivaNova
LIVN
$3.09B
-10,000
Closed -$841K
BAX icon
95
Baxter International
BAX
$12.1B
-110,000
Closed -$8.86M
INOV
96
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-600,000
Closed -$20.4M
ZLAB icon
97
Zai Lab
ZLAB
$3.48B
-35,000
Closed -$6.2M